Research exploring the potential connection between tirzepatide and Alzheimer's disease is in its early stages, with most evidence currently derived from preclinical studies and epidemiological observations rather than dedicated clinical trials
What actual customers say tells another
Miettinen MM, Antonescu CR, Fletcher CDM, Kim A, Lazar AJ, Quezado MM, et al
We understand that new treatments like retatrutide are exciting, but until they receive proper approvals, we remain committed to offering solutions that are both cutting-edge and trustworthy
Yes, typically
Dr Reddys is the most aggressive here, with 26 GLP-1 products in the pipeline and a plan to launch across 87 countries